RhumbLine Advisers’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $714K | Buy |
24,363
+6,396
| +36% | +$187K | ﹤0.01% | 2432 |
|
|
2025
Q1 | $462K | Sell |
17,967
-787
| -4% | -$20.2K | ﹤0.01% | 2629 |
|
|
2024
Q4 | $541K | Buy |
18,754
+1,100
| +6% | +$31.8K | ﹤0.01% | 2637 |
|
|
2024
Q3 | $419K | Buy |
17,654
+842
| +5% | +$20K | ﹤0.01% | 2821 |
|
|
2024
Q2 | $291K | Buy |
16,812
+12,214
| +266% | +$211K | ﹤0.01% | 3022 |
|
|
2024
Q1 | $103K | Buy |
4,598
+141
| +3% | +$3.15K | ﹤0.01% | 3439 |
|
|
2023
Q4 | $81.7K | Sell |
4,457
-359
| -7% | -$6.58K | ﹤0.01% | 3512 |
|
|
2023
Q3 | $83.6K | Buy |
4,816
+660
| +16% | +$11.5K | ﹤0.01% | 3517 |
|
|
2023
Q2 | $75.6K | Buy |
+4,156
| New | +$75.6K | ﹤0.01% | 3590 |
|
|
2022
Q2 | – | Sell |
-3,523
| Closed | -$126K | – | 3253 |
|
|
2022
Q1 | $126K | Buy |
3,523
+1,854
| +111% | +$66.3K | ﹤0.01% | 2847 |
|
|
2021
Q4 | $145K | Sell |
1,669
-9
| -0.5% | -$782 | ﹤0.01% | 2891 |
|
|
2021
Q3 | $193K | Buy |
+1,678
| New | +$193K | ﹤0.01% | 2921 |
|